Introduction {#S1}
============

G protein coupled receptors catalyze GDP (guanosine diphosphate) release on cognate G proteins through a mechanism that is not fully elucidated, however studies released in the last several years have greatly accelerated our understanding of this process. Previously, numerous structural and functional studies demonstrated the key roles that regions such as the C terminus and the α4--β6 loop of Gα play in receptor-mediated G protein activation^[@R1]--[@R7]^. However, it was not until the crystal structure of the β~2~AR (adrenergic receptor)--G~s~ complex was determined in 2011 (ref. [@R7]) that the extent of these G protein-receptor interactions could be fully appreciated. This structure provides a stunning picture of the G protein-activated receptor complex (R\*--G). What the structure alone cannot tell us is the allosteric mechanism that links interaction of a G protein with the receptor to GDP release --- the R\* and GDP binding sites are separated by 39Å. We first predicted^[@R8]^ and later demonstrated using DEER (double electron electron resonance) experiments^[@R9]^ that receptor-mediated GDP release is accompanied by opening the interface between the GTPase (guanosine triphosphatase) and helical domains in the Gα~i~ subunit. While the loss of interaction between the domains is confirmed by the crystal structure of the β~2~AR--G~s~ complex, the authors suggested that the exact location of the helical domain may be influenced by the process of crystallization. To better understand receptor mediated G protein activation, we combined DEER data with the structure of the β~2~AR-G~s~ complex to construct a unified model of the complex of activated rhodopsin with heterotrimeric Gα~i~βγ (R\*--G~i~). The model proposes the C terminus of Gα triggers conformational changes leading to GDP release and concomitant domain opening. This unified model is consistent with published EPR (electron paramagnetic resonance), deuterium exchange, and electron microscopy data. The current study has resulted in the development of a structural hypothesis for the receptor--G~i~ complex, supported by experimental data. From this structural model, we performed energetic analysis using the Rosetta force fields and identified residues that show marked energetic changes between the free G protein and G protein bound to activated receptor. Based on the energetic analysis, we propose a mechanism for receptor-mediated GDP release from the G protein. Finally, this hypothesis was validated with DEER, CW (continuous wave)-EPR, fluorescence, mutagenesis, and was consistent with previous electron microscopy and H/D (hydrogen deuterium) exchange experimental data.

Results {#S2}
=======

Our strategy included construction of a comparative model for the interaction of activated rhodopsin with G~i~ (R\*--G~i~) that unifies available experimental data with crystallographic data ([Figure 1](#F1){ref-type="fig"}, [Supplemental Movie 1](#SD2){ref-type="supplementary-material"}). The receptor unbound model of Gα~i~βγ was constructed using Rosetta, based on the PDB coordinates 1GOT^[@R10]^ which provides a higher resolution than any other G~i~ family member structure^[@R9],[@R10]^ (alignment shown in [Supplemental Figure 1](#SD1){ref-type="supplementary-material"}). The receptor-bound model of R\*--Gα~i~βγ is based on the crystal structure of the β~2~AR--G~s~ complex (PDB 3SN6^[@R7]^; alignment shown in [Supplemental Figure 2](#SD3){ref-type="supplementary-material"}). Energetic minimization of the structure utilized Rosetta's relaxation protocol with full atom energy potentials, including membrane specific terms to accommodate the receptor^[@R11],[@R12]^. Rosetta's refinement and force fields are capable of i'dentifying native structures and recovering protein backbone and side chain conformations at atomic detail accuracy^[@R13]^. The purpose was to allow the sequence dependent interactions to transition from the template structure to the interactions defined by the sequence of the target ([Supplemental Figure 3d](#SD4){ref-type="supplementary-material"}). The model with lowest Rosetta energy was the starting point for several simulations that maximize consistency with all experimental data. We systematically compared free heterotrimeric Gα~i~βγ to the receptor-bound form and analyzed amino acid interactions across key interfaces between and within the two proteins. Thereby we identified residues that contribute to stabilizing both states. We additionally mapped how these key interactions are altered when Gα~i~ interacts with R\*.

Gα C-terminal helix interactions triggers domain opening {#S3}
--------------------------------------------------------

We observed a 5.7Å translation and 63º rotation of the α5 helix. Our energetic analysis of this conformational change linked receptor-mediated changes in the α5 helix to the β6--α5 loop, the α1 and αG helices, and the GDP binding site. We hypothesize that disruption of contacts between these entities and the helical domain leads to domain separation. We determined an ensemble of models of the open state that match published data, and the ensemble reflects a wider space sampled by the helical domain than that presented in our recent work,^[@R9]^ which was published prior to the crystallographic structure of the complex. This unified model is overall consistent with the structure of the complex, with differences in the magnitude of domain separation.

Exploring possible locations of the helical domain {#S4}
--------------------------------------------------

While qualitatively consistent with the β~2~AR--G~s~ complex, the placement of the helical domain in the unified model is less dramatic than that seen in the crystal structure, based on our DEER experiments for the R\*--Gi complex^[@R9]^ ([Supplemental Table 1](#SD9){ref-type="supplementary-material"}, [Supplemental Table 2](#SD9){ref-type="supplementary-material"}). Average distances between residues in the helical and GTPase domain are less than the distances observed in the β~2~AR--G~s~ complex crystal structure. While the average interdomain distance is less than that seen in the crystal structure, the distribution of these distances is wide, consistent with a highly flexible helical domain that explores a range of conformations in the nucleotide-free state, as observed with electron crystallography^[@R13]^. Crystallization may stabilize a conformation that is not well populated in solution studies, whereas DEER captures an ensemble of conformations. We explored the possible positions of the helical domain of Gα~i~ upon receptor binding through rigid body docking with subsequent reconstruction of loop regions and energy minimization. This protocol resulted in a pool of 739 models of the receptor-bound state with different positions of the helical domain.

Helical domain positions consistent with EPR distances {#S5}
------------------------------------------------------

From this pool of docked complexes we selected an ensemble of nine models that collectively best reproduced the distance probability distributions of five different DEER distance measurements^[@R9]^ between pairs of spin-labeled residues ([Figure 2b](#F2){ref-type="fig"}, [Figure 2b](#F2){ref-type="fig"} bottom). In comparison, the ensemble of models for the basal state generated from Rosetta relaxation is less variable ([Figure 2a](#F2){ref-type="fig"}, [Figure 2a](#F2){ref-type="fig"} bottom). We converted distances between Cβ atoms (Cβ-Cβ distances) measured in the models to DEER distance probability distributions^[@R14],[@R15]^. For a given ensemble of models, these probability distributions were compared with the DEER measurement ([Supplemental Table 2](#SD9){ref-type="supplementary-material"})^[@R16]^. We compared the experimentally observed distance distributions with the distance distributions of the final ensemble model of the R\*--G~i~ complex ([Figure 3a](#F3){ref-type="fig"}).

Superimposing Gα of the generated conformations with the crystal structure of β~2~AR indicated that there are structures that agree to within a RMSD (root mean square deviation) of 2.2Å. This demonstrated that the location of the helical domain seen in the crystal structure was sampled, because there are Gα conformations which are similar to the Gα of the β~2~AR structure. This is important as these conformations could have been selected for the model ensemble if needed for agreement with the EPR data. The fact that these conformations were not selected i.e. needed for good agreement with the EPR data, suggests that they were not appreciably contributing to the conformational space sampled in our experiments.

The ensemble is consistent with single particle EM data {#S6}
-------------------------------------------------------

Westfield and co-workers^[@R13]^ performed single-particle electron microscopy (EM) analysis to examine the architecture of agonist-occupied β~2~-adrenoceptor (β~2~AR) in complex with the heterotrimeric G protein Gα~s~βγ. In their experiments, the location of the nanobody (Nβ37)-bound helical domain is variable, occupying a conformational space similar to that sampled by the helical domain in our ensemble ([Figure 3d](#F3){ref-type="fig"}, [Supplemental Movie 2](#SD2){ref-type="supplementary-material"}). The space sampled by the helical domain overlaps to a large part with the region occupied by the helical domain and nanobody in the EM study^[@R13]^. The slight deviations observed can perhaps be attributed to the negative stain EM sample preparation, which may restrict the motion of the helical domain. Regardless, there is overall agreement between the EM structure and our unified model built on DEER restraints.

Agreement of model with accessibility data {#S7}
------------------------------------------

To compare the unified model with accessibility information derived from CW-EPR and H/D exchange experiments, we computed the relative solvent accessible surface area for unbound and receptor-bound states of G~i~. The amplitude and direction of this change in exposure was compared to the experimental values which had been classified into five bins (large increase, small increase, neutral, small decrease, large decrease, [Supplemental Table 3](#SD9){ref-type="supplementary-material"} and [Supplemental Table 4](#SD9){ref-type="supplementary-material"}). As expected, we generally found that the predicted changes in accessibility exhibit similar trends to those seen in the experimental data ([Figure 3b, c](#F3){ref-type="fig"}). The correlation coefficients are 0.33 for the CW EPR measurements and 0.56 for the H/D-exchange data. Note that no perfect correlation is expected as (1) experiments capture additional aspects beyond amino acid exposure and (2) exposure is estimated from the Cβ position alone. Small deviations from perfect agreement were expected as the experimental data depend not only on solvent accessibility but also on side chain and backbone dynamics only incompletely considered in this model.

Energetic analysis of inter- and intra-domain interfaces {#S8}
--------------------------------------------------------

We examined the stabilizing interactions between key interfaces in Gα~i~ using Rosetta before and after receptor binding. Specifically, we studied four interfaces: Gα~i~-helical domain\|Gα~i~-GTPase domain interface, GDP\| Gα~i~-GTPase domain interface, C-terminal helix α5\|Gα~i~-GTPase, and R\*\|Gα~i~-GTPase domain interface. We determined interactions that stabilize these regions before and after receptor activation^[@R17]^.

Basal Gα~i~-helical domain\|Gα~i~-GTPase and GDP\|Gα~i~-GTPase interfaces {#S9}
-------------------------------------------------------------------------

The helical domain is held in place by interactions of α1 (E043, T048, K051, K054, I055) with αA (E65) and αF (Q171, L175, 5.5 Rosetta Energy Units (REUs) which correlate with kcal per mol^[@R18]^, [Figure 4a](#F4){ref-type="fig"}, [Supplemental Table 5](#SD9){ref-type="supplementary-material"}, [Supplemental Movie 3](#SD2){ref-type="supplementary-material"}). The helical domain is also fixed by electrostatic interactions of αG (K270, K277) and β4--α3 (V233, E238) loops with αA (R090), αD--αE loop (R144, Q147, D150) and αF--β2 loop (R178, 4.3 REU). Lastly, the interface is stabilized by a contact between GDP and αD--αE loop (Y154, 2.0 REU). The total interaction energy is approximately 10.1 REU. GDP is stabilized through interactions with α1 (S044, S047, T048, 3.1 REU), the helical domain (Y154, 0.8 REU), and β6--α5 loop (T327, 0.9 REU). The total interaction energy is approximately 5.1 REU ([Figure 4b](#F4){ref-type="fig"}, [Supplemental Table 5](#SD9){ref-type="supplementary-material"}, [Supplemental Movie 4](#SD2){ref-type="supplementary-material"}).

Receptor-bound R\*\|Gα~i~-GTPase domain interface {#S10}
-------------------------------------------------

The Gα C-terminal peptide (I344, N347, L348, D350, C351, L353, F354) binds to the receptor through TM3 (V138, V139, K141), TM6 (E249, V250), and TM7--αC loop (K311, Q312, 8.2 REU, [Figure 4c](#F4){ref-type="fig"}, [Supplemental Table 5](#SD9){ref-type="supplementary-material"}, [Supplemental Movie 5](#SD2){ref-type="supplementary-material"}). Further, intracellular loop 2 (F146) is interacting with αN--β1 loop at R32 (2.2 REU). The extended intracellular loop 3 (Q237, S240, T242, T243) interacts with α4 (E308), α4--β6-loop (D315, K317), and β6 (T321, 5.6 REU). The total interaction energy was approximately 17.2 REU. Comparison of residue distances for this interface with the coordinates of the β~2~ adrenergic receptor--G~s~ complex structure indicated residue E249 changes interactions most drastically, while the model ensemble showed small variation in the interface distances ([Supplemental Table 6](#SD9){ref-type="supplementary-material"}).

α5\|Gα~i~-GTPase interface rewiring upon receptor interaction {#S11}
-------------------------------------------------------------

In the basal state the C-terminal helix α5 of Gα~i~ (N331, V332, Q333, V335, F336, A338, V339, T340, V342, I343) interacts favorably with β2, β3, β5, and β6 (F191, F196, I265, F267, Y320, H322, 6.4 REU) and α1 (T048, Q52, M053, I056, 5.0 REU, [Figure 5a](#F5){ref-type="fig"}, [Supplemental Table 5](#SD9){ref-type="supplementary-material"}, [Supplemental Movie 6](#SD2){ref-type="supplementary-material"}). The β6--α5 loop (A326, T327, T329) interacts with α1 (T048, Q052, 2.5 REU) and GDP (1.4 REU).

Upon interaction with the activated receptor ([Figure 5b](#F5){ref-type="fig"}, [Supplemental Movie 7](#SD2){ref-type="supplementary-material"}), the α5 helix (I344, N347, L348, K349, D350, C351, G352, L353, F354) experiences an attraction to the receptor of 8.6 REU. This attractive interaction moves the α5 helix 5.7Å towards the receptor and triggers a rotation of the α5 helix by 63º. This is accompanied by a loss of helicity at the base of the α5 helix, which is in close proximity to bound nucleotide in the inactive heterotrimer. Thus, the base of the α5 helix appears to "melt" in the nucleotide-free state. The interaction of the α5 helix with β2, β3, β5, and β6 is modified and strengthened (F191, K192, L194, F196, I265, F267, E318, Y320, H322, 10.3 REU) upon interaction with activated receptors. At the same time, interactions of the α5 helix with α1 (T048, Q52, M053, I056, 2.2 REU) and GDP (0.2 REU) are substantially weakened. This was accompanied by loss of helical structure at the top of the α1 helix, effectively elongating the linker region between the GTPase domain and the helical domain, which may facilitate domain separation. A summary of residue stabilizations and destabilizations is shown in [Figure 5c](#F5){ref-type="fig"}.

Interactions of residues E249 and E311 of R\* changed most drastically from the coordinates of the β~2~AR--G~s~ complex structure, as measured by the change in distance to other residues in the interface. Also, the model ensemble showed small variation in the interface distances indicating the interactions were consistently predicted ([Supplemental Table 7](#SD9){ref-type="supplementary-material"}).

Helical domain position verified by DEER distances {#S12}
--------------------------------------------------

Double cysteine mutants in positions 29(αN)-68(αA) and 29(αN)-83(αA) were prepared to independently verify the position of the helical domain with respect to the GTPase domain in the unified model, and to differentiate it from the β~2~AR--G~s~ crystal structure. A cysteine depleted Gα~i~ parent protein was used as a starting point for these studies. The cysteine mutants were labeled with a thiol-selective nitroxide probe, tested for functionality, and distances were determined by DEER^[@R19],[@R20],[@R21]^. Before receptor activation, the major populations in the distribution of 29-68 and 29-83 were centered at \~31Å and \~49Å, respectively. This was consistent with the model for the unbound state ([Supplemental Figure 4a](#SD5){ref-type="supplementary-material"}, [Supplemental Table 1](#SD9){ref-type="supplementary-material"}). Upon receptor activation, the distribution was centered at \~32 Å and \~45 Å, respectively. These results were in agreement with the receptor-bound ensemble in the unified model ([Figure 6a](#F6){ref-type="fig"}), but different than that seen in the β~2~AR--G~s~ crystal structure, which predicts a substantial reduction of these distances ([Supplemental Figure 4b](#SD5){ref-type="supplementary-material"}). These results suggest that the helical domain may have been stabilized in an extreme orientation in the crystal structure. Nevertheless, the loss of interdomain contacts observed in the crystal structure is in overall agreement with our model. Our model supports a range of motion for the helical domain upon receptor activation, and the crystal structure may represent an extreme value along the continuum of possible orientations for the helical domain during signaling.

Verification of the α5 helix rotation and translation {#S13}
=====================================================

We prepared one double mutant in positions 29(αN)-330(α5) in order to test the intramolecular rearrangement of α5 after receptor activation. Both unified model and crystal structure predict a contraction of this distance. The observed distance distributions were consistent with this prediction, although the reduction was not as pronounced as in the model (compare [Figure 6a](#F6){ref-type="fig"}, [Supplemental Figure 4a](#SD5){ref-type="supplementary-material"}). The ensemble of models gives a reduction of 5.0 Å, which is in agreement with the 2.2 Å experimental distance change. Specifically, the DEER distance distributions showed a change from 30.7 Å to 28.5 Å, as calculated from their weighted averages. The ensemble of models shows a change from 31.3 Å to 26.3 Å going from the receptor unbound to receptor-bound states.

We measured the number of nearest neighbors in our model to predict changes in solvent accessibility in the β2 strand and the linker between the α-helical and GTPase domain. Using this method, the solvent accessibility of F191, located in the β~2~ strand, is predicted to decrease upon activation, while solvent accessibility of Q171, located in one of the linkers between the α-helical and GTPase domain, is predicted to increase ([Figure 6d](#F6){ref-type="fig"}). As an independent verification of our model, we individually mutated each of these residues to Cys in a Gα~i~ protein lacking solvent exposed cysteines. We then labeled each mutant protein with a fluorescent probe, and examined the polarity of the environment of the labeled residues before and after receptor activation. Increases in solvent exposure increase the polarity reported by the probe, reflected by a reduction in the fluorescence emission. An increase in the hydrophobicity of the probe's environment is typically reflected by an increase in emission from the labeled residue. As predicted by our model, residue 171 exhibited a decreased fluorescence upon receptor activation, as compared to the inactive state ([Figure 6d](#F6){ref-type="fig"}, red vs black, respectively), suggesting a more solvent exposed environment for this residue upon domain separation, this is consistent with its location in the linker region between the helical and GTPase domains. On the other hand, F191 is located in the GTPase domain, packed between the β2-sheet and α5. We observed an increased emission from labeled residue 191 upon receptor activation ([Figure 6b](#F6){ref-type="fig"}, red vs black), consistent with the increase in nearest neighbors predicted by our model. The increase and decrease in solvent exposure we observed for residues 171 and 191, respectively, were also consistent with mobility data previously reported for these residues ([Supplemental Table 3](#SD9){ref-type="supplementary-material"}, [Supplemental Table 4](#SD9){ref-type="supplementary-material"}). This is also consistent with a recent study identifying a more solvent excluded environment for the β2--β3 loop upon receptor activation ^[@R22],[@R23]^. Thus, these new data provided independent validation of the predictions from the current model, in regions which are predicted to show both increases and decreases in solvent accessibility upon receptor activation.

Four critical interface regions were used to test our model experimentally, in both basal and receptor-activated state. M53 is in the interface of the α1 helix and the α5 helix and was predicted to stabilize this interaction. F196 is in the β3-sheet and was also predicted to stabilize the interaction with the α5 helix. E308 is in the α4 helix and critical for interaction with the receptor. All four residues were predicted by the model to be critical to stabilize the stimulated state; all but E308 were predicted to be critical residues stabilizing the basal state. We mutated each residue to a cysteine, and tested basal and receptor-mediated GTP and GDP exchange for each of the mutants relative to wild type ([Figure 7b](#F7){ref-type="fig"}), and compared them to the predicted Rosetta interface energies ([Figure 7a](#F7){ref-type="fig"}). Calculations were conducted using the ensemble of models, which contain the native sequence for heterotrimer and receptor. The predicted and experimental values were consistent ([Supplemental Table 8](#SD9){ref-type="supplementary-material"}), further supporting the predictive ability of our model for identifying residues critical for receptor interaction and nucleotide exchange.

Discussion {#S14}
==========

In the current study, we highlighted changes in the orientation of the C-terminal α5 helix relative to its orientation in inactive heterotrimer, prior to binding to receptor. The energy associated with the interface of the α5 helix and surrounding regions are critically important for GDP binding and receptor-mediated GDP release. The β~2~AR--G~s~ complex was used as a template for creating a homology model of the rhodopsin--G~i~ heterotrimer complex that is the focus of our current model. Important interactions of Gα within the rhodopsin-G~i~ complex were compared to the interactions that the same regions exhibit in the inactive heterotrimer, in the absence of activated receptor. We then compared the orientation of the helical domain in the rhodopsin--Gi complex to that of the helical domain in the β~2~AR--G~s~ crystal structure in order to better understand the similarities and differences between the orientations afforded by the two different systems and methodologies involved.

There are some potential drawbacks inherent in our approach, such as perturbations of the system by the introduction of spin-labels or fluorescent probes. These can potentially perturb the biologically relevant conformation on a local or global level. Each experimental approach is aimed at a particular system under unique conditions. Coverage of experimental data is nonuniform, resulting in regions of high-confidence supported by multiple datasets and regions of low-confidence where data are sparse and/or affiliated with large error. Because of this, observations using different approaches and systems are not likely to be identical, nor do we expect them to be. Therefore, the hybrid model presented herein, like all models, is not likely to be correct in every detail, but is consistent with the current state of existing knowledge. The power of such a model is that it presents an atomic-detail hypothesis of the structure and energetics, thereby creating a roadmap for future experimental studies that can verify or reject parts of the model. In an iterative fashion, a completely verified atomic-detail model of the system can then be constructed.

The present analysis is specific for the rhodopsin--Gα~i~βγ complex. G~i~ is a close G~t~ family member which also couples to rhodopsin^[@R24]^. G~i~ was used for all experiments and modeling instead of G~t~, as G~t~ does not express well. In result, the experimental EPR data used as restraints during modeling were specific for the rhodopsin--Gα~i~βγ complex. The energetic analysis which is sequence dependent was also specific for the rhodopsin--Gα~i~βγ complex. Mutational studies conducted on this specific system confirm our model.

To what extent the findings can be generalized to other GPCR--G protein systems is an important question that remains to be determined. The location of the helical domain as described by the structural ensemble is likely to be sampled in other GPCR--G protein systems. The mechanistic model resulting from using the crystal structure (β~2~AR--G~s~) as a template, as was used here, would be expected to be similar to the extent that all GPCR--G protein systems exhibit some degree of similarity. However, specific, sequence-dependent differences likely contribute to the differences we observe, at both the G protein and GPCR level. A more rigorous and experimentally dense study focused on the individual proteins of interest will be required to study the same interactions in the β~2~AR--G~s~ or other GPCR--G protein systems.

The mechanism of receptor mediated G protein activation has been previously investigated. A "sequential release mechanism" proposes that binding of the C terminus of Gα allosterically causes the release of GDP^[@R25],[@R26]^. This qualitative observation agrees with our model, which quantitatively describes the importance of the various interactions leading to GDP release. Another previous study used molecular modeling to investigate the mechanism of GDP release from Gα upon receptor binding. Consistent with our results, they propose that a rotation of α5 is a critical step towards GDP release, and implicate the β6--α5 loop as playing a key role in propagating the signal to GDP^[@R25]^, which is supported in a mutational study examining rates of nucleotide release^[@R27]^. This study implicated an interaction between the IL2 of the receptor and the N-terminus of Gα, an interaction which our energetic analysis independently identifies as an important interaction between R\* IL 2 with the αN--β1 loop^[@R28]^. Molecular dynamics investigations of GDP release from Gα~i~βγ conducted in the absence of receptors suggested that several residues may be important for in interactions with GDP, including S44, S47, and T327 (ref. [@R29]). Molecular dynamics were also used to look at the structural changes that the Gα subunit of transducin (Gα~t~) undergoes to release GDP^[@R30]^, again in the absence of receptors. Thus, the inclusion of activated receptor in the current study presents a major advance in efforts to model the changes in Gα which occur upon receptor activation.

The relative conformational space sampled by the helical domain within the ensemble to the GTPase domain of Gα was determined using DEER. Given the small number and large uncertainty of the EPR distance measurements, the nine conformations represented in the stimulated, receptor-bound state formed a representative ensemble of conformations sampled. Furthermore, the relative conformational space sampled by the helical domain within the ensemble was wider than in our previous model, which does not take into account the distribution of distances between labeled residues upon receptor activation. This relatively wide distribution resulted in an ensemble of models which may represent the dynamic changes in the orientation of the helical domain which accompanies receptor-mediated GDP release in a physiologically relevant environment.

Other regions of the model that were derived primarily from the crystallographic template are necessarily less flexible. Since our modeling template was based on the crystal structure, the model accuracy in these regions was sufficiently high to approach atomic detail. Therefore, precise values for the 5.7 Å shift and 63° rotation of the Gα C terminus with respect to its orientation in the inactive heterotrimer are reported. In these regions, our analysis of the energetic contributions to the stability of specific interfaces between regions of Gα in the inactive heterotrimer and receptor-bound activated complex lead to the current model of the mechanism of receptor-mediated nucleotide release.

The recent determination of the crystal structure of the β~2~AR--G~s~ protein complex provides the atomic-detail insight into the interaction of a G protein with an active GPCR that was required in order to complete the present study. The availability of this experimental structure is a milestone which greatly advanced our understanding the structural determinants of the receptor--G protein complex. Using primary data and computational modeling, and taking into account the crystal structure of the β~2~AR--G~s~ complex, we obtained an ensemble of structurally dynamic states, consistent with mutational, biophysical, and structural studies that are currently available. In our model, the average interdomain separation is less dramatic than that seen in the crystal structure, but it is in qualitative agreement with it, as well as cryo-EM studies. This model integrates multiple published data and provides a detailed energetic pathway for signal transduction between activated receptor and G~i~ protein. It thereby creates a pathway to elucidate the structural and energetic determinants of signal transduction between activated receptor R\* and G~i~.

In summary, based on DEER distance measurements and the hybrid model, the rhodopsin--G~i~ complex is best represented as a structural ensemble allowing GDP release and opening of the interdomain cleft, and the Gα helical domain to sample multiple orientations. The hybrid model here represents elements from both the β~2~AR--G~s~ crystal structure and dynamic conformational changes which occur in solution as the G protein interacts with activated receptor to catalyze the release of GDP. Thus, this work provides a framework and a roadmap for future experiments including high resolution modeling of the receptor-G protein complex.

Online Methods {#S15}
==============

Receptor unbound model of Gα~i~βγ {#S16}
---------------------------------

The model of Gα~i~βγ was constructed based on the PDB coordinates 1GOT^[@R9],[@R10]^. Missing residues were reconstructed using kinematic loop closure^[@R31]^. The model of the receptor unbound state was then subjected to 100 independent relaxation trajectories that iterate between backbone perturbation, fast side chain optimization using a rotamer library^[@R32]^, and all atom gradient minimization in Rosetta full-atom force field^[@R33]^. The ten models with lowest Rosetta energy form the conformational ensemble representing Gα~i~βγ in the receptor unbound state (structures available in [Supplemental Data 1](#SD10){ref-type="supplementary-material"}). GDP was present throughout all steps of the protocol.

Receptor-bound Gα~i~βγ model consistent with experimental data {#S17}
--------------------------------------------------------------

The crystal structure of the β~2~AR--G~s~ complex (PDB 3SN6^[@R7]^) was used as the template for constructing a comparative model for the rhodopsin bound state of Gα~i~βγ. The sequence of metarhodopsin, bovine Gβ~1~ and Gγ~1~, and Gα~i~ were threaded on the 3SN6^[@R7]^ crystal structure. The receptor sequence was aligned using structure-structure alignment of 3SN6^[@R7]^ with the structure of metarhodopsin 3PQR^[@R34]^. A blast sequence alignment was used to align Gβγ. For the alpha subunit, the published sequence alignment between Gα~s~ and Gα~i~ was used^[@R35]^. For each chain, Rosetta kinematic loop closure^[@R31]^ was used to construct missing coordinates. After loop construction, the model was relaxed in Rosetta 46 times. To accommodate the receptor, the relaxation utilized Rosetta's full atom membrane potential^[@R11],[@R12]^. The model with lowest Rosetta energy was used as the starting point for the comparative model of the R\*--G~i~ complex.

No agonist was present during model construction. However, comparison of the crystal structure of activated opsin (3DQB^[@R36]^) with the β~2~AR--G~s~ complex crystal structure shows that the presence or absence of an agonist has only a small effect on the structure of the TM domain ([Supplemental Figure 5a](#SD6){ref-type="supplementary-material"}). The two receptor structures can be superimposed with an RMSD of 2.0 Å. The agonist likely stabilizes the active conformation of the β~2~AR, whereas our goal is to model the G-protein bound activated state of native rhodopsin.

Our best scoring model of activated rhodopsin aligned structurally to 2.5 Å RMSD to the β~2~AR-- G~s~ over the entire complex. The receptor in our model agreed with the crystal structure of activated rhodopsin (PDBID 3DQB^[@R36]^) to an RMSD of 2.5 Å ([Supplemental Figure 5b](#SD6){ref-type="supplementary-material"}). Importantly, the crystal structure of activated rhodopsin (PDBID 3DQB^[@R36]^) could be superimposed with the β~2~AR to 2.0 Å RMSD. This indicates that the TM domain in the model remains in an active conformation during comparative modeling even though the agonist has not been explicitly added.

No regions of the model were assumed to be correct *a priori*. The goal was to refine the model with as much experimental data as is available. However, different parts of the model were influenced by different sets of data, and the backbone conformation of the receptor and G-protein complex was only slightly refined in some regions but sampled more exhaustively in others. Portions of the model were based on (a) the crystal structure template and refinement, (b) reconstructed through comparative modeling, and (c) positioned through EPR restraints and refinement ([Supplemental Figure 3a, b, c](#SD4){ref-type="supplementary-material"}).

Additionally, multiple experimental data were used to validate the model for specific residues: CW EPR ([Supplemental Table 3](#SD9){ref-type="supplementary-material"}, [Figure 3b](#F3){ref-type="fig"}); DEER measurements ([Supplemental Table 1](#SD9){ref-type="supplementary-material"}); H/D exchange data ([Supplemental Table 4](#SD9){ref-type="supplementary-material"}, [Figure 3c](#F3){ref-type="fig"}).

Exploring possible locations of the helical domain {#S18}
--------------------------------------------------

The helical domain (residues 63 to 177) was separated from the rest of the nucleotide binding domain by removing linking residues 58--62 and 178--185. Possible placements of the helical domain were explored in 1,000 independent docking simulations. Both linker regions were reconstructed^[@R31]^ after docking and before each of these models was relaxed in the Rosetta full atom energy membrane potential^[@R11],[@R12]^. This protocol resulted in a pool of 739 non-clashing models of the receptor-bound state with different positions of the helical domain. Detailed computational and experimental protocols are given in the [supplementary note](#SD10){ref-type="supplementary-material"}.

Helical domain positions consistent with DEER distances {#S19}
-------------------------------------------------------

A subset of models was selected that optimally reproduces the DEER distances and signal shapes. DEER data were simulated for each model using the knowledge-based potential^[@R14],[@R15]^. The overall score of a given ensemble of models was the sum of the scores for the five previously published DEER distance measurements^[@R9]^. An ensemble of nine structures was selected from 1000 independent Monte Carlo simulations. This ensemble gave the best agreement between experiment and model ([Supplemental Table 2](#SD9){ref-type="supplementary-material"}). It constitutes the ensemble of the R\*--Gi complex (structures available in [Supplemental Data 2](#SD10){ref-type="supplementary-material"}).

The distance distributions seen were in most cases too large to be explained with intrinsic flexibility of the label^[@R37]^. Therefore, an implicit model of the spin label is used to describe the conformational distribution of the spin label, as detailed previously^[@R16]^. We used this method to distinguish label distribution from backbone conformational changes. Distance K29-K330 in [Figure 6a](#F6){ref-type="fig"} is an example of a distribution that is dominated by the spin label conformational distribution, with very little contribution by backbone changes in the ensemble. Distance K29-A83 in [Figure 6a](#F6){ref-type="fig"} is an example with a distribution too wide to result from label conformational changes only.

Inter- and intra-domain interface energetic analysis {#S20}
----------------------------------------------------

The energy values are reported in Rosetta Energy Units (REU) which correlate with kcal per mol ^[@R18]^. Energies are broken down on a per-residue basis to identify positions with changing interactions upon complex formation ([Figure 4](#F4){ref-type="fig"}, [Figure 5](#F5){ref-type="fig"}, [Supplemental Table 5](#SD9){ref-type="supplementary-material"}).

Materials for experimental studies {#S21}
----------------------------------

GDP and GTPγS were purchased from Sigma-Aldrich (Milwaukee, WI), and the cysteine reactive probe Alexa Fluor 595 C~5~ maleimide was purchased from Invitrogen (Madison, WI). All other reagents and chemicals were of the highest available purity. ROS membranes containing rhodopsin and Gβ~1~γ~1~ were prepared as described in^[@R6]^.

Protein expression and purification {#S22}
-----------------------------------

Gα~i~ and Gα~i~ HI proteins were expressed and purified as described previously^[@R6],\ [@R24],\ [@R40]^. Both proteins were stored at −80 °C in 50 mM Tris, 100 mM NαCl, 2 mM MgCl~2~, 1 mM DTT, 10 μM GDP and 10% glycerol (pH. 7.5).

Intrinsic Trp fluorescence and AlF~4~ activation {#S23}
------------------------------------------------

Intrinsic tryptophan fluorescence was measured as describe previously ^[@R38]^. Gα (200 nM) subunits are monitored (ex/em 280/340 nm) before and after activation with 10 μM AlF~4~ in 50 mM Tris, 100 mM NαCl, 2 mM MgCl~2~, and 10 μM GDP, pH 7.5. Evaluation of the ability of selected Gα~i~ proteins to undergo activation-dependent changes as a result of basal nucleotide exchange of GDP for BD-GTPγS was measured as described previously ^[@R39]^, with Gα~i~ HI proteins exhibiting a 10-times higher rate of exchange than wild-type proteins due to removal of solvent-exposed cysteines required for site-specific fluorescent labeling. Briefly, emission intensity of Gα~i~ protein (200 nM) was monitored at ex/em 280/340 nm before and after addition of GTPγS (10 μM). Exchange of GDP for GTPγS was determined by monitoring relative increase intrinsic Trp fluorescence, as described above. Nucleotide exchange assays are performed in buffer containing 50 mM Tris, 100 mM NαCl, 1 mM MgCl~2~, pH 7.5 at 18 ºC. Changes in fluorescence emission were determined from a minimum of three independent experiments, +SEM. Time-dependent fluorescence changes were fit to an exponential association curve using Prism 4.0 (GraphPad Software).

Protein labeling {#S24}
----------------

Gα~i~ HI proteins^[@R24]^ were labeled at a concentration of approximately 1 mg/mL in buffer free of reducing agent with a 5:1 probe:protein molar ratio in 50 mM Tris, 130 mM NαCl, 2 mM MgCl~2~ and 100 μM GDP, pH 7.5, followed by quenching with β-mercaptoethanol and removal of unbound probe with HPLC by size exclusion using a SW2000 column (Sigma-Aldrich, St. Louis, MO). Efficiency of labeling was between 25-40%. Chromatography was carried out in the same buffer supplemented with 10 μM GDP and 1 mM DTT. Monodispersity and molecular weight of the monomeric, labeled proteins was confirmed after purification by gel filtration HPLC comparing peak retention times and peak shape to results from column calibration performed with a broad range of molecular weight standards run on the same day as the purified samples (BioRad, Hercules, CA). The monomeric, labeled, purified proteins were pooled based on their ability to undergo activation-dependent changes as measured by intrinsic Trp^211^ activation (described above). Proteins with mutation of Trp^211^ were assayed by BD-GTPγS binding (described below) to ensure functional integrity of the labeled proteins.

Extrinsic fluorescence assays {#S25}
-----------------------------

For fluorescence studies of A1-labeled proteins, the emission maxima of labeled G~i~ protein (400 nM) was determined by scanning emission between 590-750 nm, with excitation at 580 nm after reconstitution of labeled Gα subunit with equimolar Gβ~1~γ~1~ subunit in buffer consisting of 50 mM Tris, 100 mM NαCl, 2 mM MgCl~2~, and 1 mM DTT, pH 7.5 at 18 ºC. All fluorescence data were analyzed as described under intrinsic Trp fluorescence.

A decrease in fluorescence after receptor activation indicates an increase in the polarity of the environment of the labeled residue, as compared to the environment in the inactive heterotrimer. A decrease in emission upon receptor activation is consistent with a more solvent exposed environment for the labeled residue. An increase in fluorescence is likewise correlated with a more hydrophobic environment, consistent with an increase in packing for the residue upon receptor activation.

Membrane binding assay {#S26}
----------------------

Membrane binding assay was evaluated as described previously^[@R40]^. Briefly, Gα~i~ (5 μM) subunits were preincubated with Gβγ (10 μM) subunits on ice for 10 min. Then, in the dark, rhodopsin (50 μM) within ROS membranes was added to the heterotrimetric G protein in a buffer containing 50 mM Tris (pH 8.0), 100 mM NαCl, 2 mM MgCl~2~ and incubated on ice for 5 min. For dark measurements, reaction mixtures were protected from light for the rest of the procedure. Light activated samples, as well as light activated samples with GTPγS (100 μM), were incubated on ice for 30 min. Membranes and supernatant were separated by centrifugation and samples were resolved by SDS-PAGE and visualized with Coomassie blue and quantified by densitometry using a BioRad Multimager. The data represent the average of three independent experiments ([Supplemental Figure 6a](#SD7){ref-type="supplementary-material"}).

Spin Labeling and DEER measurement {#S27}
----------------------------------

Spin label (S-(1-oxy-2,2,5,5,-tetramethylpyrroline-3-methyl)-methanethiosulfonate, 200mM) in DMF was mixed with Gα subunit in a 2:1 molar ratio with buffer containing 50 mM Tris (pH 7.4), 100 mM NαCl, 2 mM MgCl~2~ and 50 μM GDP. The reaction mixture was shaken gently for 16 h at 4 ºC. Unreacted spin label was removed from sample by gel filtration chromatography or extensive washing with labeling buffer by using centrifugal concentrator with a molecular mass cutoff of 10 kDa. The final labeled protein was determined by Bradford assay using bovine serum albumin as standard. All of the spin-labeled mutants showed basal and receptor mediated tryptophan fluorescent increases in the presence of GTPγS with comparable level of unlabeled Gα~i~HI protein ([Supplemental Figure 6b](#SD7){ref-type="supplementary-material"}). In addition to nucleotide exchange, they all showed the ability to form stable receptor--G protein complexes in the absence of guanine nucleotide. Double electron electron resonance (DEER) measurements were performed on a Bruker 580 pulsed EPR spectrometer operating at Q-band (33.5 GHz) using a standard four-pulse protocol^[@R41],[@R42]^. Glycerol (30% w/w) was added to the samples prior to cooling. All experiments were carried out at 83 K. Analysis of the DEER data to determine the distance distributions, P(r), was carried in DeerAnalysis 2011 (ref. [@R43]). The data was fit with Tikhonov regularization and L-curve determination of the optimal regularization parameter^[@R44]^ ([Supplemental Figure 7](#SD8){ref-type="supplementary-material"}). Some data was fitted with gaussians when the data was not adequately fit with Tikhonov regularization. For example, there are situations where the assumptions of Tikhonov regularization may not be suitable, as in the case of very broad distributions. These very broad distributions tend to have poorly defined L-curves in the typical range used to fit most data. It is in these cases that the Gaussian distributions were used to fit the data. The parameters derived from the Gaussian distribution overlap with the distribution obtained using Tikhonov regularization omitting the uncertainty in the fine structure of the distribution. To test our assay system we measured the distance between 90--238 residues before and after receptor activation and we found comparable distance distribution with the previous study^[@R9]^.
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![Overall structure of β~2~AR--G~s~ complex, our model of the R\*--G~i~ complex, and the unbound G~i~ heterotrimer. **(a)** Crystal structure of β~2~AR--Gs complex (PDB 3SN6^[@R11]^). The α5 helix of G~as~ is displaced 6Å towards the receptor and the helical domain (green) is displaced towards the membrane interface. **(b)** Unified model of the R\*--G~i~ complex: According to DEER measurements, the displacement of helical domain (green) is on average a 15Å translation and 62º rotation after receptor binding. **(c)** G~i~ heterotrimer constructed as comparative model from G~t~ (PDB 1GOT^[@R10]^) structure. Receptor (orange), Gα GTPase domain (grey), Gα helical domain (green), Gβ (light brown), Gγ (black), Nanobody (magenta), T4L (sand), GDP (in spheres).](nihms529122f1){#F1}

![Placement of helical domain and rotation of α5 as observed by EPR measurements. **(a)** G~i~ in the basal state. **(b)** G~i~ bound to activated receptor R\*. To illustrate motion, landmark residues are colored: L092 (red), E122 (green), D158 (yellow), V335 (cyan), I343 (blue). In both cases we show an ensemble of models that collectively fits the experimental data best. **(a bottom, b bottom)** Space-filled representations of the helical domain illustrate its positions for the respective states.](nihms529122f2){#F2}

![Agreement of unified model with available experimental data. **(a)** Comparison of experimental distance distribution as observed in DEER measurements (blue) with the predicted distribution computed from the unified model of the R\*--G~i~ complex (red). **(b)** Representation of the agreement with changes in accessibility observed in CW-EPR experimental data in C terminus \| Gα~i~ interface. Experimentally observed changes were classified into five groups from strong decrease (-2) to strong increase (+2). Average amino acid accessibility changes were classified likewise into five groups from strong decrease (-2) to strong increase (+2). Plotted is the difference, i.e. yellow and green colors indicate good agreement of model and experiment. **(c)** Agreement of unified model with changes in accessibility observed in deuterium exchange measurements using the same color scale as panel (b). **(d)** Agreement of unified model with single particle EM class averages.](nihms529122f3){#F3}

![Rosetta energetic analysis. **(a)** Analysis of energetics of helical domain\|Gα~i~ interface in free Gα~i~. The thickness of arrows in the top panel corresponds to the strength of the interaction in Rosetta Energy Units (REU, see legend). Residues in the bottom panel are colored by the interaction energy REU from red (repulsive) over white (neutral) to blue (attractive). Residues that contribute more than 0.5 REU are displayed as sticks and the three residues with the largest contributions are labeled. **(b)** Energetics of the GDP\|Gα~i~ interface in free Gα~i~. **(c)** Energetics of R\*\|Gα~i~ interface in the R\*-Gα~i~ complex.](nihms529122f4){#F4}

![Rosetta energetic analysis of the interface between α5\|Gα~i~-GTPase. **(a)** Basal state energetics. **(b)** Energetics of the R\*--Gα~i~ complex. Residues are colored by the interaction energy REU from red (repulsive) over white (neutral) to blue (attractive). Residues that contribute more than 0.5 REU are displayed as sticks and the three residues with the largest contributions are labeled. **(c)** Energy change (ΔREU) of C-terminal residues (β6--α5 loop and α5 helix) upon receptor binding. A blue color indicates stabilization, a red color indicates destabilization.](nihms529122f5){#F5}

![Agreement of unified model with new structural data. **(a)** Comparison of the experimental distance distribution as observed in DEER measurements (blue) with the predicted distribution computed from the ensemble mode of the R\*--Gi complex (red). **(b--d)** Comparison of accessibility of residues 171 and 191 in Gα~i~ in the basal (black) and activated state (red). **(b)** Residues 171 and 191 in a Gα~i~ protein were specifically modified with Alexa-fluor (A1), and emission (Em) was scanned at A1-specific wavelengths. **(c)** Measured fluorescence of cysteine mutants labeled with a fluorescent probe. Data represent the mean of a minimum of three independent experiments. Error bars show standard error of the mean. **(d)** Predicted burial as indicated by neighbor count based on the unified model. Bars show mean, and error bars show standard deviation.](nihms529122f6){#F6}

![Validation of the model energetic predictions. **(a)** The predicted energetic contribution to a given residue's corresponding interface is plotted for basal (black) and stimulated (red) states. Residues M53, F196, and F336 are within the α5 \| Gαi interface. Residue E308 is within the R\* \| Gαi interface, and therefore no interface contributions are predicted in the basal state. Energy is given in Rosetta Energy Units (REU). Bars show mean, and error bars show standard deviation. **(b)** Basal and receptor-mediated nucleotide exchange rates. Gαi mutant exchange rates were compared, taking the absolute value of the difference of the nucleotide exchange rate relative to wild type Gαi in both basal and receptor mediated state. Data represent between 4 -- 8 independent experiments, and error bars show standard error of the mean. The basal exchange of E308C was determined experimentally but was not significantly different from WT (wildtype), as was predicted by the model.](nihms529122f7){#F7}
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